Lb Pharmaceuticals Inc LBRX
We take great care to ensure that the data presented and summarized in this overview for LB PHARMACEUTICALS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in LBRX
Top Purchases
Top Sells
About LBRX
Insider Transactions at LBRX
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 12
2025
|
Deep Track Biotechnology Master Fund, Ltd. |
BUY
Open market or private purchase
|
Indirect |
666,666
+50.0%
|
$9,999,990
$15.0 P/Share
|
Sep 12
2025
|
Deep Track Biotechnology Master Fund, Ltd. |
BUY
Open market or private purchase
|
Direct |
2,000,000
+42.68%
|
$30,000,000
$15.0 P/Share
|
Sep 12
2025
|
Deep Track Biotechnology Master Fund, Ltd. |
BUY
Conversion of derivative security
|
Direct |
686,138
+50.0%
|
-
|
Sep 12
2025
|
Ran Nussbaum |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+41.46%
|
$15,000,000
$15.0 P/Share
|
Sep 12
2025
|
Ran Nussbaum |
BUY
Conversion of derivative security
|
Indirect |
411,681
+50.0%
|
-
|
Sep 12
2025
|
Pontifax Management 4 G.P. (2015) Ltd. |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+41.46%
|
$15,000,000
$15.0 P/Share
|
Sep 12
2025
|
Pontifax Management 4 G.P. (2015) Ltd. |
BUY
Conversion of derivative security
|
Indirect |
411,681
+50.0%
|
-
|
Sep 12
2025
|
Vida Ventures Gp Iii, L.L.C. |
BUY
Open market or private purchase
|
Indirect |
333,333
+27.43%
|
$4,999,995
$15.0 P/Share
|
Sep 12
2025
|
Vida Ventures Gp Iii, L.L.C. |
BUY
Conversion of derivative security
|
Indirect |
548,910
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
7.06M
Shares
From
8
Insiders
Conversion of derivative security | 2.06M shares |
---|---|
Open market or private purchase | 5M shares |
Sell / Disposition
0
Shares
From
0
Insiders